NAFLD1
MONDO:0021105Also known as: NAFLD1, fatty liver disease, nonalcoholic, susceptibility to, 1, liver disease, alcoholic, susceptibility to, 1
5 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Can fatty liver in children lead to serious liver disease? a Long-Term study aims to find out
Knowledge-focused Recruiting nowThis study follows children aged 1 to 18 with biopsy-confirmed nonalcoholic fatty liver disease (NAFLD) to track how the condition changes over time. Researchers will monitor for liver-related death, cirrhosis complications, and the need for liver transplants. The goal is to bett…
Sponsor: Humanity and Health Research Centre • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
New drug tested in patients with fatty liver and cirrhosis
Knowledge-focused Recruiting nowThis early-stage study tests a single dose of an experimental drug called efimosfermin alfa in 32 adults with fatty liver disease and varying degrees of liver damage. The goal is to see how the drug moves through the body and whether it is safe. Participants must have liver cirrh…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC